Pembrolizumab bound to PD1

3D print of Pembrolizumab (KEYTRUDA) bound to PD-1. Model available in multiple materials and sizes. “Pembrolizumab (formerly MK-3475and lambrolizumab, trade name Keytruda)[1] is a humanized antibodyused in cancer immunotherapy. It destroys a protective mechanism on cancer cells, and allows the immune system to destroy those cancer cells. It targets the programmed cell death 1(PD-1) receptor. The drug was initially used in treating metastatic melanoma.”

Protein Description

Pembrolizumab is a compact antibody used in the treatment of various cancers, most notably indicated for use when EGFR inhibitors fail to reach treatment outcomes. Scientists identified the programmed cell death 1 receptor, PD-1, a protective mechanism on the surface of cancer cells. Pembrolizumab binds to this receptor allowing for the immune system cells to successfully recognize and destroy cancer cells.

Purchase 3D Print of Pembrolizumab


Models available in multiple sizes.

, , , ,

Comments are closed.
%d bloggers like this: